{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T14:10:01Z","timestamp":1722175801361},"reference-count":4,"publisher":"American Psychiatric Association Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2001,3,1]]},"DOI":"10.1176\/appi.ajp.158.3.498-a","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:28:01Z","timestamp":1034360881000},"page":"498-a-499","source":"Crossref","is-referenced-by-count":1,"title":["Pramipexole Augmentation in Panic  With Agoraphobia"],"prefix":"10.1176","volume":"158","author":[{"given":"DONATELLA","family":"MARAZZITI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SILVIO","family":"PRESTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHIARA","family":"PFANNER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LILIANA","family":"DELL\u2019OSSO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIOVANNI B.","family":"CASSANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R1583BCFGEEJC","doi-asserted-by":"crossref","unstructured":"Parkinson Study Group: Safety and efficacy of pramipexole in early Parkinson disease: a randomized dose-ranging study. JAMA 1997; 278:125\u2013130","DOI":"10.1001\/jama.278.2.125"},{"key":"R1583BCFBHEEC","doi-asserted-by":"crossref","unstructured":"Goldberg JF, Frye MA, Dunn RT: Pramipexole in refractory bipolar depression (letter). Am J Psychiatry 1999; 156:798","DOI":"10.1176\/ajp.156.5.798"},{"key":"R1583BCFJJCEB","doi-asserted-by":"crossref","unstructured":"Kasper S, Barnas C, Heiden A, Volz HP, Laakmann G, Zeit H, Pfolz H: Pramipexole as adjunct to haloperidol in schizophrenia: safety and efficacy. Eur Neuropsychopharmacol 1997; 7:65\u201370","DOI":"10.1016\/S0924-977X(96)00393-8"},{"key":"R1583BCFHEFBD","doi-asserted-by":"crossref","unstructured":"Rosenbaum JF, Fredman SJ: Pramipexole treatment for cocaine cravings (letter). Am J Psychiatry 1999; 156:1834","DOI":"10.1176\/ajp.156.11.1834"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.158.3.498-a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T13:33:28Z","timestamp":1722173608000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.158.3.498-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,1]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3,1]]}},"alternative-id":["10.1176\/appi.ajp.158.3.498-a"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.158.3.498-a","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,1]]}}}